Study identifies new target in treating mesothelioma

July 3, 2012, University of Hawaii at Manoa
July 1, 2012 cover of Cancer Research

(Medical Xpress) -- An international team of researchers, led by Haining Yang, PhD, from the University of Hawai‘i Cancer Center, has identified HMGB1 as a critical protein in the pathogenesis of malignant mesothelioma, one of the most dangerous forms of cancer highly related to asbestos and erionite exposure. The findings are featured as the cover story of the July 1, 2012 issue of Cancer Research, one of the nation's leading cancer research publications.

“We are very excited about this discovery and are extremely pleased that it was also chosen to be the featured cover story,” said Yang. “The next step is to translate this discovery into actual treatments for patients.”

The discovery outlines the process causing the growth of mesothelioma and offers scientists an opportunity to develop specific therapies for treatment. Mesothelioma is an aggressive cancer usually diagnosed at late stages and is resistant to current treatments. The average survival rate is less than one year. However, five percent of patients diagnosed at an early stage have survival rates of five to 10 years or more. The identification of this new biomarker for early detection will help shed light on developing novel targets for mesothelioma prevention and therapy.

Mesothelioma has been linked to occupational and environmental exposure to asbestos. Erionite, a naturally occurring mineral fiber, also causes mesothelioma. In the United States, approximately 3,000 cases of mesothelioma are diagnosed each year. It has been estimated that over 25 million people have been exposed to asbestos in the U.S., while the amount of those exposed to erionite is unknown.

The UH Cancer Center is a global leader in mesothelioma research. The center’s thoracic oncology team led by Director Michele Carbone, MD, PhD, and Yang, has also been instrumental in several other recent discoveries including the identification of the gene that causes mesothelioma, BAP1.

The current study was an international effort and included investigators from the University of Hawai‘i Cancer Center, the John A Burns School of Medicine in Honolulu, the San Raffaele University and Research Institute in Milan, Italy, the National Institutes of Health in Bethesda, Md., and the New York University School of Medicine.

Explore further: Scientists find genetic link to mesothelioma

Related Stories

Scientists find genetic link to mesothelioma

August 28, 2011
Scientists have found that individuals who carry a mutation in a gene called BAP1 are susceptible to developing two forms of cancer – mesothelioma, and melanoma of the eye. Additionally, when these individuals are exposed ...

New study finds cancer-causing mineral in US road gravel

July 25, 2011
As school buses drive down the gravel roads in Dunn County, North Dakota, they stir up more than dirt. The clouds of dust left in their wake contain such high levels of the mineral erionite that those who breathe in the air ...

Renal cancer drug temsirolimus shows promise against mesothelioma

May 1, 2011
A drug commonly used to treat kidney cancer may increase the effectiveness of chemotherapy for mesothelioma, according to a study published in the May issue of the Journal of Thoracic Oncology.

Photodynamic therapy added to lung-sparing surgery improves survival for mesothelioma patients

May 30, 2012
(Medical Xpress) -- Among patients with malignant pleural mesothelioma, treatment with lung-sparing surgery in combination with photodynamic therapy (PDT) yielded unusually long survival rates, with median survival rates ...

Recommended for you

Stem cell vaccine immunizes lab mice against multiple cancers

February 15, 2018
Stanford University researchers report that injecting mice with inactivated induced pluripotent stem cells (iPSCs) launched a strong immune response against breast, lung, and skin cancers. The vaccine also prevented relapses ...

Induced pluripotent stem cells could serve as cancer vaccine, researchers say

February 15, 2018
Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or ...

Team paves the way to the use of immunotherapy to treat aggressive colon tumors

February 15, 2018
In a short space of time, immunotherapy against cancer cells has become a powerful approach to treat cancers such as melanoma and lung cancer. However, to date, most colon tumours appeared to be unresponsive to this kind ...

Can our genes help predict how women respond to ovarian cancer treatment?

February 15, 2018
Research has identified gene variants that play a significant role in how women with ovarian cancer process chemotherapy.

First comparison of common breast cancer tests finds varied accuracy of predictions

February 15, 2018
Commercially-available prognostic breast cancer tests show significant variation in their abilities to predict disease recurrence, according to a study led by Queen Mary University of London of nearly 800 postmenopausal women.

Catching up to brain cancer: Researchers develop accurate model of how aggressive cancer cells move and spread

February 15, 2018
A brief chat at a Faculty Senate meeting put two University of Delaware researchers onto an idea that could be of great value to cancer researchers.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.